BIIB Related Upgrades

May 1, 2013 06:45 AM Goldman Sachs Upgrades Amgen (AMGN) to Conviction Buy

Apr 12, 2013 09:00 AM BofA/Merrill Lynch Upgrades Biogen (BIIB) to Buy

Feb 27, 2013 07:38 AM Canaccord Genuity Upgrades Biogen (BIIB) to Buy

Feb 8, 2013 06:53 AM Citi Upgrades Biogen (BIIB) to Buy

Sep 10, 2012 12:55 PM UBS on U.S. Biotechnology - Updating Outlook on Covered Stocks (GILD, AMGN, BIIB, CELG, INCY, IDIX, VRTX, SGEN)

Apr 4, 2012 06:57 AM Goldman Sachs Upgrades Biogen (BIIB) to Buy, Sees 16% Upside

Nov 28, 2011 06:49 AM Goldman Sachs Adds Gilead Sciences (GILD) to the Conviction Buy List on Acquisition Strategy

Oct 26, 2011 03:12 PM BMO Upgraded Biogen (BIIB) Earlier Following Positive Data on BG-12

Oct 3, 2011 09:45 AM William Blair Upgrades Biogen (BIIB) to Outperform

Sep 9, 2011 10:31 AM UPDATE - UBS Upgraded Biogen (BIIB) to Buy; Reason to Believe in BG-12’s CONFIRM

Sep 9, 2011 08:14 AM UBS Upgrades Biogen (BIIB) to Buy

Aug 18, 2011 07:25 AM Oppenheimer Upgrades Biogen (BIIB) to Outperform

Jun 22, 2011 07:27 AM Credit Suisse Upgrades Biogen (BIIB) to Outperform

Jun 21, 2011 06:45 AM Deutsche Bank Upgrades Biogen (BIIB) to Buy

Jun 20, 2011 08:20 AM ISI Group Upgrades Biogen (BIIB) to Buy

Apr 25, 2011 07:44 AM Goldman Sachs Removes 'Sell' Rating from Biogen (BIIB)

Apr 21, 2011 01:57 PM Piper Jaffray Upgrades Biogen (BIIB) to Overweight, Raises Target to $129

Apr 21, 2011 11:31 AM Oppenheimer Upgrades Biogen (BIIB) Following Strong BG-12 Trial Data, Q1 Earnings

Apr 13, 2011 01:37 PM Stifel Nicolaus Upgrades Biogen (BIIB) to Hold

Apr 12, 2011 10:02 AM BofA/Merrill Lynch Upgrades Biogen (BIIB) to Buy Following Positive Oral BG-12 Data

Apr 11, 2011 12:26 PM BMO Upgrades Biogen (BIIB) to Market Perform Following Positive Trial Results for Oral BG-12

Feb 24, 2011 08:07 AM RBC Capital Upgrades Biogen (BIIB), Regeneron (REGN) to Outperform, Downgrades Celgene (CELG) to Sector Perform

Jan 5, 2010 08:13 AM Bank of America Upgrades Biogen Idec (BIIB) to Neutral

Nov 2, 2009 09:43 AM Jefferies & Co Upgrades Biogen Idec (BIIB) to Buy

Jul 2, 2009 08:47 AM Leerink Swann Upgrades Acorda Therapeutics (ACOR) Two-Notches to Outperform

May 20, 2009 01:12 PM Barclays Gets Bullish On US Biotechnology Sector (BBH)

May 20, 2009 07:47 AM Barclays Upgrades Biogen Idec (BIIB) to Equalweight

Jan 27, 2009 07:25 AM Goldman Sachs Upgrades Biogen Idec (BIIB) to Buy, Adds To Buy List

Nov 3, 2008 08:21 AM Deutsche Bank Upgrades Biogen Idec (BIIB) to Buy

Nov 3, 2008 07:18 AM Baird Upgrades Biogen Idec (BIIB) to Outperform

Oct 29, 2008 07:55 AM UBS Upgrades Biogen Idec (BIIB) to Neutral

Oct 28, 2008 08:56 AM Cowen & Co Upgrades Biogen Idec (BIIB) to Outperform, Calls Best Value In Biotech

Sep 25, 2008 08:50 AM Lazard Capital Upgrades Biogen Idec (BIIB) to Buy

Jul 22, 2008 02:50 PM BMO Upgrades Biogen (BIIB) to Outperform

Jul 21, 2008 08:49 AM Biogen-Idec (BIIB): Upgraded to Buy at Merrill Lynch

Jul 21, 2008 07:42 AM Merrill Lynch Upgrades Biogen Idec (BIIB) to Buy

Jan 17, 2008 07:39 AM Banc of America upgrades Biogen Idec (BIIB) to Buy

Jan 15, 2008 09:04 AM BWS Financial Upgrades Biogen (BIIB) to Buy; $70 PT

Dec 13, 2007 09:24 AM Piper Jaffray Upgrades Biogen Idec (BIIB) to Neutral

Dec 13, 2007 08:04 AM Credit Suisse Upgrades Biogen Idec (BIIB) to Neutral

Nov 13, 2007 09:36 AM BWS Financial Upgrades Biogen (BIIB) to Hold

Mar 6, 2007 08:13 AM BWS Financial upgrades Biogen Idec Inc. (BIIB) to Buy

Nov 20, 2006 07:46 AM Lehman Brothers upgrades Biogen (BIIB) to Overweight

Oct 30, 2006 07:21 AM Bear Stearns upgrades Biogen Idec (BIIB) to Peer Perform

Jul 27, 2006 09:14 AM Sanford C Bernstein upgrades Biogen Idec (BIIB) to Market Perform

Mar 8, 2006 03:50 PM Deutsche Bank upgraded BIIB to Buy

Oct 31, 2005 07:24 AM JP Morgan upgrades BIIB to Overweight

Apr 28, 2005 07:18 AM Deutsche Bank upgrades BIIB to Hold

Mar 1, 2005 07:59 AM Smith Barney upgrades BIIB to Buy

Feb 8, 2005 07:56 AM Bear Stearns Upgrades Biogen Idec